10,098
Views
36
CrossRef citations to date
0
Altmetric
Review Article

Sleeping Beauty transposition: from biology to applications

, , &
Pages 18-44 | Received 27 Jul 2016, Accepted 14 Sep 2016, Published online: 04 Oct 2016

References

  • Alessio AP, Fili AE, Garrels W, et al. (2016). Establishment of cell-based transposon-mediated transgenesis in cattle. Theriogenology 85:1297–311. e2.
  • Ammar I, Gogol-Doring A, Miskey C, et al. (2012a). Retargeting transposon insertions by the adeno-associated virus Rep protein. Nucleic Acids Res 40:6693–712.
  • Ammar I, Izsvak Z, Ivics Z. (2012b). The Sleeping Beauty transposon toolbox. Methods Mol Biol 859:229–40.
  • Aravind L, Anantharaman V, Balaji S, et al. (2005). The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 29:231–62.
  • Aronovich EL, Bell JB, Belur LR, et al. (2007). Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses. J Gene Med 9:403–15.
  • Aronovich EL, Bell JB, Khan SA, et al. (2009). Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system. Mol Ther 17:1136–44.
  • Balasubramanian S, Rajendra Y, Baldi L, et al. (2016). Comparison of three transposons for the generation of highly productive recombinant CHO cell pools and cell lines. Biotechnol Bioeng 113:1234–43.
  • Balciunas D, Davidson AE, Sivasubbu S, et al. (2004). Enhancer trapping in zebrafish using the Sleeping Beauty transposon. BMC Genomics 5:62.
  • Bard-Chapeau EA, Nguyen AT, Rust AG, et al. (2014). Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model. Nat Genet 46:24–32.
  • Baus J, Liu L, Heggestad AD, et al. (2005). Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 12:1148–56.
  • Been RA, Linden MA, Hager CJ, et al. (2014). Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in mice. PLoS One 9:e97280.
  • Belay E, Matrai J, Acosta-Sanchez A, et al. (2010). Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation. Stem Cells 28:1760–71.
  • Belur LR, Frandsen JL, Dupuy AJ, et al. (2003). Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 8:501–7.
  • Belur LR, Podetz-Pedersen KM, Sorenson BS, et al. (2011). Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol Cancer 10:14.
  • Bender AM, Collier LS, Rodriguez FJ, et al. (2010). Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res 70:3557–65.
  • Benjamin HW, Kleckner N. (1989). Intramolecular transposition by Tn10. Cell 59:373–83.
  • Berry C, Hannenhalli S, Leipzig J, Bushman FD. (2006). Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2:e157.
  • Boehme P, Doerner J, Solanki M, et al. (2015). The sleeping beauty transposon vector system for treatment of rare genetic diseases: an unrealized hope? Curr Gene Ther 15:255–65.
  • Borchert GM, Holton NW, Williams JD, et al. (2011). Comprehensive analysis of microRNA genomic loci identifies pervasive repetitive-element origins. Mob Genet Elements 1:8–17.
  • Bosch P, Forcato DO, Alustiza FE, et al. (2015). Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals. Cell Mol Life Sci 72:1907–29.
  • Bouuaert CC, Tellier M, Chalmers R. (2014). One to rule them all: a highly conserved motif in mariner transposase controls multiple steps of transposition. Mob Genet Elements 4:e28807.
  • Bowers WJ, Mastrangelo MA, Howard DF, et al. (2006). Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther 13:580–8.
  • Braun CJ, Boztug K, Paruzynski A, et al. (2014). Gene therapy for Wiskott-Aldrich syndrome–long-term efficacy and genotoxicity. Sci Transl Med 6:227ra33.
  • Carlson CM, Dupuy AJ, Fritz S, et al. (2003). Transposon mutagenesis of the mouse germline. Genetics 165:243–56.
  • Carlson CM, Frandsen JL, Kirchhof N, et al. (2005). Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. Proc Natl Acad Sci USA 102:17059–64.
  • Carpentier CE, Schreifels JM, Aronovich EL, et al. (2014). NMR structural analysis of Sleeping Beauty transposase binding to DNA. Protein Sci 23:23–33.
  • Chen CL, Tseng YW, Wu JC, et al. (2015). Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Biomaterials 44:71–81.
  • Chen HJ, Wei Z, Sun J, et al. (2016). A recellularized human colon model identifies cancer driver genes. Nat Biotechnol 34:845–51.
  • Chen ZJ, Kren BT, Wong PY, et al. (2005). Sleeping Beauty-mediated down-regulation of Huntington expression by RNA interference. Biochem Biophys Res Commun 329:646–52.
  • Ciuffi A, Llano M, Poeschla E, et al. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11:1287–9.
  • Claeys Bouuaert C, Lipkow K, Andrews SS, et al. (2013). The autoregulation of a eukaryotic DNA transposon. eLife 2:e00668.
  • Collier LS, Adams DJ, Hackett CS, et al. (2009). Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69:8429–37.
  • Copeland NG, Jenkins NA. (2010). Harnessing transposons for cancer gene discovery. Nat Rev Cancer 10:696–706.
  • Cordaux R, Batzer MA. (2009). The impact of retrotransposons on human genome evolution. Nat Rev Genet 10:691–703.
  • Craig NL. (1995). Unity in transposition reactions. Science 270:253–4.
  • Cui Z, Geurts AM, Liu G, et al. (2002). Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon. J Mol Biol 318:1221–35.
  • Czerny T, Schaffner G, Busslinger M. (1993). DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev 7:2048–61.
  • Davidson AE, Balciunas D, Mohn D, et al. (2003). Efficient gene delivery and gene expression in zebrafish using the Sleeping Beauty transposon. Dev Biol 263:191–202.
  • Davis RP, Nemes C, Varga E, et al. (2013). Generation of induced pluripotent stem cells from human fetal fibroblasts using the Sleeping Beauty transposon gene delivery system. Differentiation 86:30–7.
  • De Jong J, Akhtar W, Badhai J, et al. (2014). Chromatin landscapes of retroviral and transposon integration profiles. PLoS Genet 10:e1004250.
  • De Rijck J, De Kogel C, Demeulemeester J, et al. (2013). The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep 5:886–94.
  • De Silva S, Mastrangelo MA, Lotta LT, Jr. et al. (2010a). Extending the transposable payload limit of Sleeping Beauty (SB) using the herpes simplex virus (HSV)/SB amplicon-vector platform. Gene Ther 17:424–31.
  • De Silva S, Mastrangelo MA, Lotta LT, Jr. et al. (2010b). Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo. Hum Gene Ther 21:1603–13.
  • Deichmann A, Hacein-Bey-Abina S, Schmidt M, et al. (2007). Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 117:2225–32.
  • Deniger DC, Pasetto A, Tran E, et al. (2016). Stable, nonviral expression of mutated tumor neoantigen-specific T-cell receptors using the Sleeping Beauty transposon/transposase system. Mol Ther 24:1078–89.
  • Di Matteo M, Belay E, Chuah MK, Vandendriessche T. (2012). Recent developments in transposon-mediated gene therapy. Expert Opin Biol Ther 12:841–58.
  • Dorr C, Janik C, Weg M, et al. (2015). Transposon mutagenesis screen identifies potential lung cancer drivers and CUL3 as a tumor suppressor. Mol Cancer Res 13:1238–47.
  • Dupuy AJ, Clark K, Carlson CM, et al. (2002). Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci USA 99:4495–9.
  • Dupuy AJ, Fritz S, Largaespada DA. (2001). Transposition and gene disruption in the male germline of the mouse. Genesis 30:82–8.
  • Elso CM, Chu EP, Alsayb MA, et al. (2015). Sleeping Beauty transposon mutagenesis as a tool for gene discovery in the NOD mouse model of type 1 diabetes. G3 (Bethesda) 5:2903–11.
  • Escobar H, Schowel V, Spuler S, et al. (2016). Full-length dysferlin transfer by the hyperactive Sleeping Beauty transposase restores dysferlin-deficient muscle. Mol Ther Nucleic Acids 5:e277.
  • Fatima A, Ivanyuk D, Herms S, et al. (2016). Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2. Stem Cell Res 16:304–7.
  • Fischer SE, Wienholds E, Plasterk RH. (2001). Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci USA 98:6759–64.
  • Galla M, Schambach A, Falk CS, et al. (2011). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res 39:7147–60.
  • Garcia Diaz AI, Moyon B, Coan PM, et al. (2016). New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent protein. Dis Model Mech 9:463–71.
  • Garfinkel DJ, Stefanisko KM, Nyswaner KM, et al. (2006). Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap. J Virol 80:11920–34.
  • Garrels W, Mates L, Holler S, et al. (2011). Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS One 6:e23573.
  • Garrels W, Mukherjee A, Holler S, et al. (2016a). Identification and re-addressing of a transcriptionally permissive locus in the porcine genome. Transgenic Res 25:63–70.
  • Garrels W, Talluri TR, Apfelbaum R, et al. (2016b). One-step multiplex transgenesis via Sleeping Beauty transposition in cattle. Sci Rep 6:21953.
  • Garrels W, Talluri TR, Ziegler M, et al. (2016c). Cytoplasmic injection of murine zygotes with Sleeping Beauty transposon plasmids and minicircles results in the efficient generation of germline transgenic mice. Biotechnol J 11:178–84.
  • Geurts AM, Hackett CS, Bell JB, et al. (2006). Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res 34:2803–11.
  • Geurts AM, Yang Y, Clark KJ, et al. (2003). Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol Ther 8:108–17.
  • Gogol-Doring A, Ammar I, Gupta S, et al. (2016). Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4 T cells. Mol Ther 24:592–606.
  • Grabher C, Henrich T, Sasado T, et al. (2003). Transposon-mediated enhancer trapping in medaka. Gene 322:57–66.
  • Grabundzija I, Irgang M, Mates L, et al. (2010). Comparative analysis of transposable element vector systems in human cells. Mol Ther 18:1200–9.
  • Grabundzija I, Wang J, Sebe A, et al. (2013). Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res 41:1829–47.
  • Gupta SS, Maetzig T, Maertens GN, et al. (2013). Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 87:12721–36.
  • Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132–42.
  • Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–19.
  • Hackett PB, Largaespada DA, Switzer KC, Cooper LJ. (2013). Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy. Transl Res 161:265–83.
  • Hausl MA, Zhang W, Muther N, et al. (2010). Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Mol Ther 18:1896–906.
  • He CX, Shi D, Wu WJ, et al. (2004). Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration. World J Gastroenterol 10:567–72.
  • He X, Li J, Long Y, et al. (2013). Gene transfer and mutagenesis mediated by Sleeping Beauty transposon in Nile tilapia (Oreochromis niloticus). Transgenic Res 22:913–24.
  • Henssen AG, Henaff E, Jiang E, et al. (2015). Genomic DNA transposition induced by human PGBD5. eLife 2015;4:e10565. doi: 10.7554/eLife.10565.
  • Hickman AB, Chandler M, Dyda F. (2010). Integrating prokaryotes and eukaryotes: DNA transposases in light of structure. Crit Rev Biochem Mol Biol 45:50–69.
  • Horie K, Kuroiwa A, Ikawa M, et al. (2001). Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci USA 98:9191–6.
  • Horie K, Yusa K, Yae K, et al. (2003). Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol Cell Biol 23:9189–207.
  • Hou X, Du Y, Deng Y, et al. (2015). Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers. Cancer Biol Ther 16:8–16.
  • Howe SJ, Mansour MR, Schwarzwaelder K, et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118:3143–50.
  • Hozumi A, Mita K, Miskey C, et al. (2013). Germline transgenesis of the chordate Ciona intestinalis with hyperactive variants of sleeping beauty transposable element. Dev Dyn 242:30–43.
  • Hu S, Ni W, Sai W, et al. (2011). Sleeping Beauty-mediated knockdown of sheep myostatin by RNA interference. Biotechnol Lett 33:1949–53.
  • Huang CR, Burns KH, Boeke JD. (2012). Active transposition in genomes. Annu Rev Genet 46:651–75.
  • Huang X, Guo H, Tammana S, et al. (2010). Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 18:1803–13.
  • Ivics Z. (2016). Endogenous transposase source in human cells mobilizes piggyBac transposons. Mol Ther 24:851–4.
  • Ivics Z, Garrels W, Mates L, et al. (2014a). Germline transgenesis in pigs by cytoplasmic microinjection of Sleeping Beauty transposons. Nat Protoc 9:810–27.
  • Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501–10.
  • Ivics Z, Hiripi L, Hoffmann OI, et al. (2014b). Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons. Nat Protoc 9:794–809.
  • Ivics Z, Izsvak Z. (2006). Transposons for gene therapy!. Curr Gene Ther 6:593–607.
  • Ivics Z, Izsvak Z. (2010). The expanding universe of transposon technologies for gene and cell engineering. Mob DNA 1:25.
  • Ivics Z, Izsvak Z. (2011). Nonviral gene delivery with the sleeping beauty transposon system. Hum Gene Ther 22:1043–51.
  • Ivics Z, Izsvak Z. (2015). Sleeping Beauty transposition. Microbiol Spectr 3:MDNA3–0042. 2014.
  • Ivics Z, Izsvak Z, Minter A, Hackett PB. (1996). Identification of functional domains and evolution of Tc1-like transposable elements. Proc Natl Acad Sci USA 93:5008–13.
  • Ivics Z, Katzer A, Stuwe EE, et al. (2007). Targeted Sleeping Beauty transposition in human cells. Mol Ther 15:1137–44.
  • Ivics Z, Kaufman CD, Zayed H, et al. (2004). The Sleeping Beauty transposable element: evolution, regulation and genetic applications. Curr Issues Mol Biol 6:43–55.
  • Ivics Z, Mates L, Yau TY, et al. (2014c). Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons. Nat Protoc 9:773–93.
  • Izsvak Z, Hackett PB, Cooper LJ, Ivics Z. (2010). Translating Sleeping Beauty transposition into cellular therapies: victories and challenges. Bioessays 32:756–67.
  • Izsvak Z, Ivics Z. (2004). Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther 9:147–56.
  • Izsvak Z, Ivics Z, Plasterk RH. (2000). Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302:93–102.
  • Izsvak Z, Khare D, Behlke J, et al. (2002). Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition. J Biol Chem 277:34581–8.
  • Izsvak Z, Stuwe EE, Fiedler D, et al. (2004). Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells. Mol Cell 13:279–90.
  • Izsvak Z, Wang J, Singh M, et al. (2016). Pluripotency and the endogenous retrovirus HERVH: conflict or serendipity? Bioessays 38:109–17.
  • Johnen S, Izsvak Z, Stocker M, et al. (2012). Sleeping Beauty transposon-mediated transfection of retinal and iris pigment epithelial cells. Invest Ophthalmol Vis Sci 53:4787–96.
  • Jursch T, Miskey C, Izsvak Z, Ivics Z. (2013). Regulation of DNA transposition by CpG methylation and chromatin structure in human cells. Mob DNA 4:15.
  • Kaji K, Norrby K, Paca A, et al. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771–5.
  • Katter K, Geurts AM, Hoffmann O, et al. (2013). Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J 27:930–41.
  • Keng VW, Villanueva A, Chiang DY, et al. (2009). A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27:264–74.
  • Keng VW, Yae K, Hayakawa T, et al. (2005). Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat Methods 2:763–9.
  • Kokubu C, Horie K, Abe K, et al. (2009). A transposon-based chromosomal engineering method to survey a large cis-regulatory landscape in mice. Nat Genet 41:946–52.
  • Kost TA, Condreay JP, Jarvis DL. (2005). Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567–75.
  • Kowarz E, Loscher D, Marschalek R. (2015). Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines. Biotechnol J 10:647–53.
  • Kren BT, Unger GM, Sjeklocha L, et al. (2009). Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest 119:2086–99.
  • Krishnamurthy J, Rabinovich BA, Mi T, et al. (2015). Genetic engineering of T cells to target HERV-K, an ancient retrovirus on melanoma. Clin Cancer Res 21:3241–51.
  • Kues WA, Herrmann D, Barg-Kues B, et al. (2013). Derivation and characterization of sleeping beauty transposon-mediated porcine induced pluripotent stem cells. Stem Cells Dev 22:124–35.
  • Kurtti TJ, Mattila JT, Herron MJ, et al. (2008). Transgene expression and silencing in a tick cell line: a model system for functional tick genomics. Insect Biochem Mol Biol 38:963–8.
  • Lander ES, Linton LM, Birren B, et al. (2001). Initial sequencing and analysis of the human genome. Nature 409:860–921.
  • Li MA, Turner DJ, Ning Z, et al. (2011). Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res 39:e148
  • Liu D, Chalmers R. (2014). Hyperactive mariner transposons are created by mutations that disrupt allosterism and increase the rate of transposon end synapsis. Nucleic Acids Res 42:2637–45.
  • Liu G, Geurts AM, Yae K, et al. (2005). Target-site preferences of Sleeping Beauty transposons. J Mol Biol 346:161–73.
  • Liu L, Liu H, Visner G, Fletcher BS. (2006a). Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J 20:2594–6.
  • Liu L, Mah C, Fletcher BS. (2006b). Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Mol Ther 13:1006–15.
  • Lobo NF, Fraser TS, Adams JA, Fraser MJ. Jr. (2006). Interplasmid transposition demonstrates piggyBac mobility in vertebrate species. Genetica 128:347–57.
  • Lu B, Geurts AM, Poirier C, et al. (2007). Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system. Mamm Genome 18:338–46.
  • Luo G, Ivics Z, Izsvak Z, Bradley A. (1998). Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci USA 95:10769–73.
  • Luo WY, Shih YS, Hung CL, et al. (2012). Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy. Gene Ther 19:844–51.
  • Magnani CF, Turazzi N, Benedicenti F, et al. (2016). Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform. Oncotarget7:51581–97.
  • Maiti SN, Huls H, Singh H, et al. (2013). Sleeping beauty system to redirect T-cell specificity for human applications. J Immunother 36:112–23.
  • Maldarelli F, Wu X, Su L, et al. (2014). HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345:179–83.
  • Mann MB, Jenkins NA, Copeland NG, Mann KM. (2014). Sleeping Beauty mutagenesis: exploiting forward genetic screens for cancer gene discovery. Curr Opin Genet Dev 24:16–22.
  • Marg A, Escobar H, Gloy S, et al. (2014). Human satellite cells have regenerative capacity and are genetically manipulable. J Clin Invest 124:4257–65.
  • Marie C, Vandermeulen G, Quiviger M, et al. (2010). pFARs, plasmids free of antibiotic resistance markers, display high-level transgene expression in muscle, skin and tumor cells. J Gene Med 12:323–32.
  • Mates L, Chuah MK, Belay E, et al. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41:753–61.
  • Maxwell A, Craigie R, Mizuuchi K. (1987). B protein of bacteriophage mu is an ATPase that preferentially stimulates intermolecular DNA strand transfer. Proc Natl Acad Sci USA 84:699–703.
  • Mingozzi F, High KA. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341–55.
  • Moldt B, Miskey C, Staunstrup NH, et al. (2011). Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells. Mol Ther 19:1499–510.
  • Moldt B, Yant SR, Andersen PR, et al. (2007). Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors. Hum Gene Ther 18:1193–204.
  • Molyneux SD, Waterhouse PD, Shelton D, et al. (2014). Human somatic cell mutagenesis creates genetically tractable sarcomas. Nat Genet 46:964–72.
  • Montini E, Held PK, Noll M, et al. (2002). In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther 6:759–69.
  • Moriarity B, Largaespada DA. (2011). A comprehensive guide to Sleeping Beauty-based somatic transposon mutagenesis in the mouse. Curr Protoc Mouse Biol 1:347–68.
  • Moriarity BS, Otto GM, Rahrmann EP, et al. (2015). A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nat Genet 47:615–24.
  • Muenthaisong S, Ujhelly O, Polgar Z, et al. (2012). Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping Beauty transposon mediated gene transfer. Exp Cell Res 318:2482–9.
  • Muses S, Morgan JE, Wells DJ. (2011). Restoration of dystrophin expression using the Sleeping Beauty transposon. PLoS Curr 3:RRN1296.
  • Ohlfest JR, Demorest ZL, Motooka Y, et al. (2005a). Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol Ther 12:778–88.
  • Ohlfest JR, Frandsen JL, Fritz S, et al. (2005b). Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 105:2691–8.
  • Ohlfest JR, Ivics Z, Izsvak Z. (2009). Transposable elements as plasmid-based vectors for long-term gene transfer into tumors. Methods Mol Biol 542:105–16.
  • Ohlfest JR, Lobitz PD, Perkinson SG, Largaespada DA. (2004). Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system. Mol Ther 10:260–8.
  • Okita K, Ichisaka T, Yamanaka S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313–17.
  • Ortiz-Urda S, Lin Q, Yant SR, et al. (2003). Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther 10:1099–104.
  • Pan XJ, Ma ZZ, Zhang QJ, et al. (2012). Sleeping Beauty transposon system is a reliable gene delivery tool for hereditary tyrosinaemia type 1 disease gene therapy: size of the foreign gene decides the timing of stable integration into the host chromosomes. J Int Med Res 40:1850–9.
  • Peterson EB, Mastrangelo MA, Federoff HJ, Bowers WJ. (2007). Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type composition. Mol Ther 15:1848–55.
  • Petrakis S, Rasko T, Mates L, et al. (2012). Gateway-compatible transposon vector to genetically modify human embryonic kidney and adipose-derived stromal cells. Biotechnol J 7:891–7.
  • Pettersen EF, Goddard TD, Huang CC, et al. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25:1605–12.
  • Piriyapongsa J, Jordan IK. (2007). A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One 2:e203
  • Plasterk RH, Izsvak Z, Ivics Z. (1999). Resident aliens: the Tc1/mariner superfamily of transposable elements. Trends Genet 15:326–32.
  • Prak ET, Kazazian HH. Jr., (2000). Mobile elements and the human genome. Nat Rev Genet 1:134–44.
  • Quintana RM, Dupuy AJ, Bravo A, et al. (2013). A transposon-based analysis of gene mutations related to skin cancer development. J Invest Dermatol 133:239–48.
  • Rahrmann EP, Collier LS, Knutson TP, et al. (2009). Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res 69:4388–97.
  • Rahrmann EP, Watson AL, Keng VW, et al. (2013). Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 45:756–66.
  • Rauschhuber C, Ehrhardt A. (2012). RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration. PLoS One 7:e35389.
  • Raz E, Van Luenen HG, Schaerringer B, et al. (1998). Transposition of the nematode Caenorhabditis elegans Tc3 element in the zebrafish Danio rerio. Curr Biol 8:82–8.
  • Rice PA, Baker TA. (2001). Comparative architecture of transposase and integrase complexes. Nat Struct Biol 8:302–7.
  • Richardson JM, Colloms SD, Finnegan DJ, Walkinshaw MD. (2009). Molecular architecture of the Mos1 paired-end complex: the structural basis of DNA transposition in a eukaryote. Cell 138:1096–108.
  • Riordan JD, Drury LJ, Smith RP, et al. (2014). Sequencing methods and datasets to improve functional interpretation of sleeping beauty mutagenesis screens. BMC Genomics 15:1150.
  • Robert VJ, Vastenhouw NL, Plasterk RH. (2004). RNA interference, transposon silencing, and cosuppression in the Caenorhabditis elegans germ line: similarities and differences. Cold Spring Harb Symp Quant Biol 69:397–402.
  • Rostovskaya M, Fu J, Obst M, et al. (2012). Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res 40:e150
  • Schouten GJ, Van Luenen HG, Verra NC, et al. (1998). Transposon Tc1 of the nematode Caenorhabditis elegans jumps in human cells. Nucleic Acids Res 26:3013–17.
  • Schroder AR, Shinn P, Chen H, et al. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521–9.
  • Sharma A, Larue RC, Plumb MR, et al. (2013a). BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci USA 110:12036–41.
  • Sharma N, Cai Y, Bak RO, et al. (2013b). Efficient sleeping beauty DNA transposition from DNA minicircles. Mol Ther Nucleic Acids 2:e74.
  • Shoemaker C, Hoffman J, Goff SP, Baltimore D. (1981). Intramolecular integration within Moloney murine leukemia virus DNA. J Virol 40:164–72.
  • Sievers F, Wilm A, Dineen D, et al. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539.
  • Sijen T, Plasterk RH. (2003). Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 426:310–14.
  • Singh H, Figliola MJ, Dawson MJ, et al. (2013). Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells. PLoS One 8:e64138.
  • Singh H, Moyes JS, Huls MH, Cooper LJ. (2015). Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor. Cancer Gene Ther 22:95–100.
  • Sinzelle L, Vallin J, Coen L, et al. (2006). Generation of trangenic Xenopus laevis using the Sleeping Beauty transposon system. Transgenic Res 15:751–60.
  • Smalheiser NR, Torvik VI. (2005). Mammalian microRNAs derived from genomic repeats. Trends Genet 21:322–6.
  • Song G, Cui Z. (2013). Novel strategies for gene trapping and insertional mutagenesis mediated by Sleeping Beauty transposon. Mob Genet Elements 3:e26499.
  • Song J, Kim C, Ochoa ER. (2009). Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma. Biosci Biotechnol Biochem 73:165–8.
  • Starr TK, Allaei R, Silverstein KA, et al. (2009). A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323:1747–50.
  • Starr TK, Scott PM, Marsh BM, et al. (2011). A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis. Proc Natl Acad Sci USA 108:5765–70.
  • Staunstrup NH, Moldt B, Mates L, et al. (2009). Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol Ther 17:1205–14.
  • Staunstrup NH, Sharma N, Bak RO, et al. (2011). A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogs. BMC Biotechnol 11:33.
  • Stein S, Ott MG, Schultze-Strasser S, et al. (2010). Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16:198–204.
  • Szebenyi K, Furedi A, Kolacsek O, et al. (2015). Generation of a homozygous transgenic rat strain stably expressing a calcium sensor protein for direct examination of calcium signaling. Sci Rep 5:12645.
  • Talluri TR, Kumar D, Glage S, et al. (2015). Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming. Cell Reprogram 17:131–40.
  • Thrasher AJ, Gaspar HB, Baum C, et al. (2006). Gene therapy: X-SCID transgene leukaemogenicity. Nature 443:E5–6. discussion E6-7.
  • Tschida BR, Largaespada DA, Keng VW. (2014). Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies. Semin Cell Dev Biol 27:86–95.
  • Turchiano G, Latella MC, Gogol-Doring A, et al. (2014). Genomic analysis of Sleeping Beauty transposon integration in human somatic cells. PLoS One 9:e112712.
  • Turunen TA, Kurkipuro J, Heikura T, et al. (2016). Sleeping Beauty transposon vectors in liver-directed gene delivery of LDLR and VLDLR for gene therapy of familial hypercholesterolemia. Mol Ther 24:620–35.
  • Turunen TA, Laakkonen JP, Alasaarela L, et al. (2014). Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye. J Gene Med 16:40–53.
  • Van Der Weyden L, Giotopoulos G, Rust AG, et al. (2011). Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 118:1041–51.
  • Van Gent DC, Hiom K, Paull TT, Gellert M. (1997). Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J 16:2665–70.
  • Vastenhouw NL, Fischer SE, Robert VJ, et al. (2003). A genome-wide screen identifies 27 genes involved in transposon silencing in C. elegans. Curr Biol 13:1311–16.
  • Vastenhouw NL, Plasterk RH. (2004). RNAi protects the Caenorhabditis elegans germline against transposition. Trends Genet 20:314–19.
  • Vigdal TJ, Kaufman CD, Izsvak Z, et al. (2002). Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol 323:441–52.
  • Vink CA, Gaspar HB, Gabriel R, et al. (2009). Sleeping Beauty transposition from nonintegrating lentivirus. Mol Ther 17:1197–204.
  • Voigt F, Wiedemann L, Zuliani C, et al. (2016). Sleeping Beauty transposase structure allows rational design of hyperactive variants for genetic engineering. Nat Commun 7:11126.
  • Voigt K, Gogol-Doring A, Miskey C, et al. (2012). Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains. Mol Ther 20:1852–62.
  • Vos JC, De Baere I, Plasterk RH. (1996). Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev 10:755–61.
  • Wagner TA, Mclaughlin S, Garg K, et al. (2014). HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345:570–3.
  • Walisko O, Ivics Z. (2006). Interference with cell cycle progression by parasitic genetic elements: sleeping beauty joins the club. Cell Cycle 5:1275–80.
  • Walisko O, Izsvak Z, Szabo K, et al. (2006). Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1. Proc Natl Acad Sci USA 103:4062–7.
  • Walisko O, Schorn A, Rolfs F, et al. (2008). Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 16:359–69.
  • Wang DD, Yang M, Zhu Y, Mao C. (2015). Reiterated targeting peptides on the nanoparticle surface significantly promote targeted vascular endothelial growth factor gene delivery to stem cells. Biomacromolecules 16:3897–903.
  • Wang J, Singh M, Sun C, et al. (2016). Isolation and cultivation of naive-like human pluripotent stem cells based on HERVH expression. Nat Protoc 11:327–46.
  • Wang J, Xie G, Singh M, et al. (2014a). Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells. Nature 516:405–9.
  • Wang X, Sarkar DP, Mani P, et al. (2009). Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon. Hepatology 50:815–24.
  • Wang Y, Wang J, Devaraj A, et al. (2014b). Suicidal autointegration of sleeping beauty and piggyBac transposons in eukaryotic cells. PLoS Genet 10:e1004103.
  • Wang Y, Wang J, Devaraj A, et al. (2014c). Suicidal autointegration of Sleeping Beauty and piggyBac transposons in eukaryotic cells. PLoS Genet 10:e1004103. doi: 10.1371/journal.pgen.1004103.
  • Wilber A, Wangensteen KJ, Chen Y, et al. (2007). Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther 15:1280–7.
  • Williams DA. (2008). Sleeping beauty vector system moves toward human trials in the United States. Mol Ther 16:1515–16.
  • Woltjen K, Michael IP, Mohseni P, et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766–70.
  • Wu X, Li Y, Crise B, Burgess SM. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749–51.
  • Xiao J, Meng XM, Huang XR, et al. (2012). miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20:1251–60.
  • Xue X, Huang X, Nodland SE, et al. (2009). Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114:1319–30.
  • Yamada M, Ohkawara B, Ichimura N, et al. (2003). Negative regulation of Wnt signalling by HMG2L1, a novel NLK-binding protein. Genes Cells 8:677–84.
  • Yant SR, Ehrhardt A, Mikkelsen JG, et al. (2002). Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol 20:999–1005.
  • Yant SR, Huang Y, Akache B, Kay MA. (2007). Site-directed transposon integration in human cells. Nucleic Acids Res 35:e50.
  • Yant SR, Kay MA. (2003). Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol 23:8505–18.
  • Yant SR, Meuse L, Chiu W, et al. (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25:35–41.
  • Yant SR, Park J, Huang Y, et al. (2004). Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 24:9239–47.
  • Yant SR, Wu X, Huang Y, et al. (2005). High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 25:2085–94.
  • Yum SY, Lee SJ, Kim HM, et al. (2016). Efficient generation of transgenic cattle using the DNA transposon and their analysis by next-generation sequencing. Sci Rep 6:27185.
  • Yusa K, Rad R, Takeda J, Bradley A. (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363–9.
  • Yusa K, Takeda J, Horie K. (2004). Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol Cell Biol 24:4004–18.
  • Zayed H, Izsvak Z, Khare D, et al. (2003). The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res 31:2313–22.
  • Zayed H, Izsvak Z, Walisko O, Ivics Z. (2004). Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 9:292–304.
  • Zhang W, Solanki M, Muther N, et al. (2013). Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells. PLoS One 8:e76771.